-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Reiterates Overweight on West Pharmaceutical Servs, Maintains $360 Price Target

Benzinga·06/02/2026 12:48:17
Listen to the news
Stephens & Co. analyst Steven Etoch reiterates West Pharmaceutical Servs (NYSE:WST) with a Overweight and maintains $360 price target.